Table 2.
Demographic, patient characteristics, and follow-up data in global sample and subgroups.
| Autologous Techniques n = 9 |
Allograft Reconstruction n = 8 |
Global Sample n = 17 |
Significance | |
|---|---|---|---|---|
| Sex (M/F) | 8 M/1 F | 6 M/2 F | 14 M/3 F | 0.00 |
| Age (years) | 40.55 ± 15.5 (24–69) | 45.37 ± 12.68 (27–67) | 42.82 ± 14.02 (24–69) | 0.33 |
| Metabolic disorders (%) * | 6 (66.6%) | 6 (75%) | 12 (70.5%) | 0.71 |
| Gap (cms) | 4.33 ± 1.32 (3–6.5) | 7.75 ± 0.88 (7–9) | 5.94 ± 2.07 (3–9) | 0.00 |
| Follow-up (months) | 76.33 ± 36.33 (36–136) | 88.75 ± 38.22 (26–150) | 82.17 ± 36.60 (26–150) | 0.42 |
* Obesity, hypercholesterolemia, diabetes mellitus, or thyroid disorders.